TTC39B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.566600E-01
Normal-vs-Stage2
9.557200E-01
Normal-vs-Stage3
1.083380E-01
Normal-vs-Stage4
2.826800E-01
Stage1-vs-Stage2
8.486400E-01
Stage1-vs-Stage3
1.353970E-01
Stage1-vs-Stage4
1.641600E-01
Stage2-vs-Stage3
9.174200E-04
Stage2-vs-Stage4
1.402390E-01
Stage3-vs-Stage4
1.049740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.078200E-01
Normal-vs-AfricanAmerican
3.868200E-01
Normal-vs-Asian
8.589400E-01
Caucasian-vs-AfricanAmerican
1.675620E-01
Caucasian-vs-Asian
8.657800E-01
AfricanAmerican-vs-Asian
1.926220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.189000E-01
Normal-vs-Female
8.264800E-01
Male-vs-Female
7.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.933400E-01
Normal-vs-Age(41-60Yrs)
9.786000E-01
Normal-vs-Age(61-80Yrs)
8.931800E-01
Normal-vs-Age(81-100Yrs)
3.982600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.064200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.790200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.686200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.388200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.239200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.938640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.711800E-01
Normal-vs-Daily Drinker
3.644200E-01
Normal-vs-Weekly Drinker
8.103600E-01
Normal-vs-Occasional Drinker
6.553600E-01
Normal-vs-Social Drinker
9.118200E-01
Non Drinker-vs-Daily Drinker
1.948010E-01
Non Drinker-vs-Weekly Drinker
4.677600E-01
Non Drinker-vs-Occasional Drinker
6.048200E-01
Non Drinker-vs-Social Drinker
9.158200E-01
Daily Drinker-vs-Weekly Drinker
4.683800E-02
Daily Drinker-vs-Occasional Drinker
4.801200E-01
Daily Drinker-vs-Social Drinker
1.944400E-01
Weekly Drinker-vs-Occasional Drinker
2.350800E-01
Weekly Drinker-vs-Social Drinker
5.623000E-01
Occasional Drinker-vs-Social Drinker
5.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.928560E-01
Normal-vs-Grade 2
5.423600E-02
Normal-vs-Grade 3
4.192200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.270000E-01
Grade 1-vs-Grade 3
3.538400E-01
Grade 1-vs-Grade 4
1.928560E-01
Grade 2-vs-Grade 3
4.744200E-01
Grade 2-vs-Grade 4
5.423600E-02
Grade 3-vs-Grade 4
4.192200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.092800E-01
Normal-vs-NonDiabetic
6.209000E-01
Diabetic-vs-NonDiabetic
4.284200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.579400E-01
Normal-vs-NoPancreatitis
7.562400E-01
Pancreatitis-vs-NoPancreatitis
7.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.237200E-01
Normal-vs-N1
8.924200E-01
N0-vs-N1
9.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.694800E-01
Normal-vs-TP53-NonMutant
8.845800E-01
TP53-Mutant-vs-TP53-NonMutant
5.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
